Sign In
Buy AGRX
$1.51
+0 (+0%)
At Close: Nov 25, 2024
Agile Therapeutics: Bullish On Capitulation And Max Pain
04:05pm, Tuesday, 19'th Oct 2021
Agile Therapeutics: Bullish On Capitulation And Max Pain
Top Penny Stocks to Watch Making Big Moves Right Now
09:09am, Tuesday, 19'th Oct 2021
If you're making a penny stocks watchlist right now, check these three small-caps out The post Top Penny Stocks to Watch Making Big Moves Right Now appeared first on Penny Stocks to Buy, Picks, News a
AGRX Stock: Why It Fell This Past Week
08:50am, Wednesday, 13'th Oct 2021
The stock price of Agile Therapeutics Inc (NASDAQ: AGRX) fell over 20% this past week. This is why it happened.
Best Biotech Penny Stocks on Reddit to Buy Now? 4 For Your Watchlist
04:07pm, Tuesday, 12'th Oct 2021
Looking for biotech penny stocks to watch on Reddit? Check these four out for your list The post Best Biotech Penny Stocks on Reddit to Buy Now?
PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today applauded House Congressional Committee leaders in urging the Secretari
Agile Therapeutics Appoints Josephine Torrente to its Board of Directors
04:05pm, Friday, 08'th Oct 2021
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Josephine Torrente has been appointed to the Company's bo
Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of Common Stock and Warrants
08:30am, Friday, 08'th Oct 2021
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the pricing of its underwritten public offering of 26,666,648
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Warrants
04:05pm, Thursday, 07'th Oct 2021
PRINCETON, N.J., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that it intends to offer and sell shares of its common stock a
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal Formulary
08:02am, Monday, 04'th Oct 2021
Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021 Largest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021
Agile Therapeutics to Participate in Upcoming Investor Conferences
07:30am, Tuesday, 07'th Sep 2021
PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the followin
PRINCETON, N.J., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced a partnership with Pandia Health, an online telehealth servic
Agile Therapeutics: Another Quarter Of Progress And Another Opportunity To Buy
01:18pm, Friday, 30'th Jul 2021
Agile Therapeutics recently reported their Q2 earnings with a beat on EPS and a miss on revenue. The company's flagship product, Twirla, is already starting to display impressive growth trends. The ma
2 Penny Stocks Insiders Are Buying
10:11am, Friday, 30'th Jul 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their ove
3 Penny Stocks Insiders Are Buying
09:34am, Thursday, 29'th Jul 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their ove
Agile Therapeutics, Inc.'s (AGRX) CEO Al Altomari on Q2 2021 Results - Earnings Call Transcript
10:50pm, Monday, 26'th Jul 2021
Agile Therapeutics, Inc.'s (AGRX) CEO Al Altomari on Q2 2021 Results - Earnings Call Transcript
